Peptide induces CD4+CD25+ and IL-10+ T cells and protection in airway allergy models

Vaccine

Volumn 23, Issue 24, 2005, Pages 3181-3186

  Zuleger, Cindy L ^a   Gao, Xiaoyan ^a   Burger, Melissa S ^a   Chu, Qili ^a   Payne, Lendon G ^a   Chen, Dexiang ^a,b  

^a PowderJect Vaccines Inc   (United States)

^b PATH   (United States)

Author keywords

Bystander suppression; House dust mite allergy; Peptide vaccine; Peripheral tolerance; Regulatory T cells

Indexed keywords

CD4 ANTIGEN; HOUSE DUST ALLERGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; SERYLASPARAGINYLTYROSYLCYSTEINYLGLUTAMINYLISOLEUCYLTYROSYLPROLYLPROLYL ASPARAGINYLALANYLASPARAGINYLLYSYLISOLEUCYLARGININE; UNCLASSIFIED DRUG; VACCINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATOPHAGOIDES; DRUG SCREENING; EOSINOPHILIA; FEMALE; IMMUNOLOGICAL TOLERANCE; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; T LYMPHOCYTE;

EID: 17044407928     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.12.012     Document Type: Article

References (15)

1. D.S. Robinson, Q. Hamid, and S. Ying Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma N Engl J Med 326 5 1992 298 304
2. G.F. Hoyne, R.E. O'Hehir, D.C. Wraith, W.R. Thomas, and J.R. Lamb Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice J Exp Med 178 5 1993 1783 1788
3. + T cells precedes the development of tolerance in vivo Int Immunol 8 3 1996 335 342
4. A.G. Jarnicki, T. Tsuji, and W.R. Thomas Inhibition of mucosal and systemic Th2-type immune responses by intranasal peptides containing a dominant T cell epitope of the allergen Der p 1 Int Immunol 13 10 2001 1223 1231
5. G. Hall, C.G. Houghton, J.U. Rahbek, J.R. Lamb, and E.R. Jarman Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production Vaccine 21 5-6 2003 549 561
6. W.L. Oldfield, M. Larche, and A.B. Kay Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial Lancet 360 9326 2002 47 53
7. W.L. Oldfield, A.B. Kay, and M. Larche Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects J Immunol 167 3 2001 1734 1739
8. U. Muller, C.A. Akdis, M. Fricker, M. Akdis, T. Blesken, and F. Bettens Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom J Allergy Clin Immunol 101 6 Pt 1 1998 747 754
9. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 J Immunol 166 5 2001 3008 3018
10. S. Read, V. Malmstrom, and F. Powrie CytotoxicT lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation J Exp Med 192 2 2000 295 302
11. H. Jonuleit, E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop, and A.H. Enk Identification and functional characterization of human CD4(+)CD25 (+) T cells with regulatory properties isolated from peripheral blood J Exp Med 193 11 2001 1285 1294
12. C. Asseman, S. Mauze, M.W. Leach, R.L. Coffman, and F. Powrie An essential role for interleukin-10 in the function of regulatory T cells that inhibit intestinal inflammation J Exp Med 190 7 1999 995 1004
13. H. Groux, A. O'Garra, and M. Bigler A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis Nature 389 6652 1997 737 742
14. C.A. Akdis, T. Blesken, M. Akdis, B. Wuthrich, and K. Blaser Role of interleukin-10 in specific immunotherapy J Clin Invest 102 1 1998 98 106
15. + T cells in the control of inflammation J Immunol 171 10 2003 5018 5026